10 completed. 9 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 9 | Completed 9 |
| Phase 3 | 1 | Completed 1 |
Follow Mesoestetic Pharma Group S.L.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Safety and Performance Characteristics of Mesofiller Mesotox for the Correction of Wrinkles and Rehydration of the Face. mesofiller® mesotox - Skin Aging, Skin Wrinkling | Not applicable | Completed | Mesoestetic Pharma Group S.L. | 52 | 2022-11-15 | 2024-06-27 |
| Evaluation of the Safety and Performance Characteristics of Mesofiller Aox for the Correction of Mild and Moderate Facial Wrinkles. mesofiller aox - Skin Aging, Skin Wrinkling | Not applicable | Completed | Mesoestetic Pharma Group S.L. | 55 | 2022-10-03 | 2024-07-03 |
| Clinical Investigation to Assess Safety and Performance of Dermal Filler of Hyaluronic Acid LIFT001 - Skin Folds, Wrinkle | Not applicable | Completed | Mesoestetic Pharma Group S.L. | 50 | 2022-08-02 | 2024-02-05 |
| Efficacy and Performance Evaluation of mGlobal L+AS 20 mg/ml Hyaluronic Acid, for the Correction of Light to Moderate Wrinkles and Folds mGlobal L+AS - Skin Aging, Skin Wrinkling | Not applicable | Completed | Mesoestetic Pharma Group S.L. | 42 | 2022-03-03 | 2024-07-01 |
| Efficacy and Performance Evaluation of mIntense L+AS 25 mg/ml Hyaluronic Acid for the Correction of Moderate to Deep Wrinkles and Folds mIntense L+AS - Skin Aging, Skin Wrinkling | Not applicable | Completed | Mesoestetic Pharma Group S.L. | 42 | 2022-02-03 | 2024-06-11 |
| Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of the Vagina. MMG-23-04-2019 - Vaginal Atrophy, Vulvovaginal Signs and Symptoms | Not applicable | Completed | Mesoestetic Pharma Group S.L. | 37 | 2019-11-11 | 2020-12-09 |
| Evaluation of the Efficacy and Safety of the Dermal Filler for Augmentation of Labia Majora. MMI-22-04-2019 - Labia Majora Atrophy and Hypotrophy | Not applicable | Completed | Mesoestetic Pharma Group S.L. | 35 | 2019-11-11 | 2020-12-03 |
| Pilot Trial to Assess the Performance and Tolerance of mRDX-02-17 Dermal Filler in the Facial Rejuvenation mRDX-02-17 - Facial Rejuvenation | Not applicable | Completed | Mesoestetic Pharma Group S.L. | 39 | 2018-10-29 | 2019-10-01 |
| Assessment of the Safety and Efficacy of the Dermal Filler "mARG-01-17" in Facial Rejuvenation Therapy mARG-01-17 (mesohyal AGRIBENONE) - Facial Rejuvenation | Not applicable | Completed | Mesoestetic Pharma Group S.L. | 40 | 2018-08-30 | 2020-11-25 |
| Efficacy and Safety of a 4% Hydroquinone Cream for the Treatment of Melasma Hydroquinone, Placebo - Facial Melasma | Phase 3 | Completed | Mesoestetic Pharma Group S.L. | 17 | 2014-03-01 | 2019-09-30 |
Dyspareunia (1) · Urinary Incontinence (1)
hydroquinone (1)
Bulgaria (7) · Spain (2) · Romania (1)
Luis Luis, MD (1) · Susana Puig, MD (1) · Tatyana Bayateva, MD (1)